1.Perioperative complications associated with routine preoperative glucocorticoid use among patients undergoing pituitary surgery with normal preoperative HPA axis: A retrospective cohort study.
Franz Michael MAGNAYE ; Elizabeth PAZ-PACHECO
Journal of the ASEAN Federation of Endocrine Societies 2025;40(1):89-96
OBJECTIVE
This study determined the incidence of perioperative complications associated with routine preoperative glucocorticoid use in patients undergoing pituitary surgery with normal preoperative hypothalamo-pituitary-adrenal axis (HPA axis).
METHODOLOGYFrom 2011-2021 retrospective chart review, 243 patients undergoing pituitary surgery with normal preoperative HPA axis were analyzed into 2 groups: 1) with preoperative steroids and 2) without preoperative steroids. Development of postoperative complications was subsequently evaluated.
RESULTSIncidence of primary composite postoperative complications of in-hospital mortality, postoperative infection and postoperative diabetes insipidus (DI) was significantly increased among those who had preoperative steroids compared to those without (58.33% versus 33.33%, p-value 0.004) with an adjusted odds ratio of 2.90 (CI 1.29 to 6.53, p-value 0.010). Among the components of the composite outcome, post-operative DI was statistically higher among those who were given preoperative steroids (52.45% versus 28.21%, p-value 0.006) with an adjusted OR of 3.31 (CI 1.43 to 7.67, p-value 0.005). The incidence of postoperative adrenal insufficiency was similar between the 2 groups (20.15% with steroids versus 8.70% without steroids, p-value 0.258).
CONCLUSIONAmong patients with normal preoperative HPA axis, the routine use of preoperative steroids is associated with an increased risk of composite postoperative complications (in-hospital mortality, postoperative infection and postoperative DI). Steroid-sparing protocol is not associated with an increased risk of postoperative AI. The findings will encourage more rational use of steroids and minimize preventable complications.
Human ; Pituitary-adrenal System ; Pituitary Gland ; Postoperative Complications ; Glucocorticoids ; Steroids
2.Pathogens of first-episode pulmonary infection in 141 children with chronic granulomatous disease.
Hui LIU ; Shunying ZHAO ; Haiming YANG ; Jinrong LIU ; Hui XU ; Xiaolei TANG ; Yuelin SHEN ; Xiaoyan ZHANG ; Xiaohui WEN ; Yuhong ZHAO ; Ping CHU ; Huimin LI
Chinese Medical Journal 2024;137(4):502-504
3.O-arm navigation versus C-arm navigation for guiding percutaneous long sacroiliac screws placement in treatment of Denis type Ⅱ sacral fractures.
Wei ZHOU ; Guodong WANG ; Xuan PEI ; Zhixun FANG ; Yu CHEN ; Suyaolatu BAO ; Jianan CHEN ; Ximing LIU
Chinese Journal of Reparative and Reconstructive Surgery 2024;38(1):28-34
OBJECTIVE:
To compare the effectiveness of O-arm navigation and C-arm navigation for guiding percutaneous long sacroiliac screws in treatment of Denis type Ⅱ sacral fractures.
METHODS:
A retrospective study was conducted on clinical data of the 46 patients with Denis type Ⅱ sacral fractures between April 2021 and October 2022. Among them, 19 patients underwent O-arm navigation assisted percutaneous long sacroiliac screw fixation (O-arm navigation group), and 27 patients underwent C-arm navigation assisted percutaneous long sacroiliac screw fixation (C-arm navigation group). There was no significant difference in gender, age, causes of injuries, Tile classification of pelvic fractures, combined injury, the interval from injury to operation between the two groups ( P>0.05). The intraoperative preparation time, the placement time of each screw, the fluoroscopy time of each screw during placement, screw position accuracy, the quality of fracture reduction, and fracture healing time were recorded and compared, postoperative complications were observed. Pelvic function was evaluated by Majeed score at last follow-up.
RESULTS:
All operations were completed successfully, and all incisions healed by first intention. Compared to the C-arm navigation group, the O-arm navigation group had shorter intraoperative preparation time, placement time of each screw, and fluoroscopy time, with significant differences ( P<0.05). There was no significant difference in screw position accuracy and the quality of fracture reduction ( P>0.05). There was no nerve or vascular injury during screw placed in the two groups. All patients in both groups were followed up, with the follow-up time of 6-21 months (mean, 12.0 months). Imaging re-examination showed that both groups achieved bony healing, and there was no significant difference in fracture healing time between the two groups ( P>0.05). During follow-up, there was no postoperative complications, such as screw loosening and breaking or loss of fracture reduction. At last follow-up, there was no significant difference in pelvic function between the two groups ( P>0.05).
CONCLUSION
Compared with the C-arm navigation, the O-arm navigation assisted percutaneous long sacroiliac screws for the treatment of Denis typeⅡsacral fractures can significantly shorten the intraoperative preparation time, screw placement time, and fluoroscopy time, improve the accuracy of screw placement, and obtain clearer navigation images.
Humans
;
Fracture Fixation, Internal/methods*
;
Retrospective Studies
;
Imaging, Three-Dimensional
;
Bone Screws
;
Surgery, Computer-Assisted
;
Tomography, X-Ray Computed
;
Spinal Fractures/surgery*
;
Fractures, Bone/surgery*
;
Pelvic Bones/injuries*
;
Postoperative Complications
;
Neck Injuries
5.Fangji Fuling Decoction Alleviates Sepsis by Blocking MAPK14/FOXO3A Signaling Pathway.
Yi WANG ; Ming-Qi CHEN ; Lin-Feng DAI ; Hai-Dong ZHANG ; Xing WANG
Chinese journal of integrative medicine 2024;30(3):230-242
OBJECTIVE:
To examine the therapeutic effect of Fangji Fuling Decoction (FFD) on sepsis through network pharmacological analysis combined with in vitro and in vivo experiments.
METHODS:
A sepsis mouse model was constructed through intraperitoneal injection of 20 mg/kg lipopolysaccharide (LPS). RAW264.7 cells were stimulated by 250 ng/mL LPS to establish an in vitro cell model. Network pharmacology analysis identified the key molecular pathway associated with FFD in sepsis. Through ectopic expression and depletion experiments, the effect of FFD on multiple organ damage in septic mice, as well as on cell proliferation and apoptosis in relation to the mitogen-activated protein kinase 14/Forkhead Box O 3A (MAPK14/FOXO3A) signaling pathway, was analyzed.
RESULTS:
FFD reduced organ damage and inflammation in LPS-induced septic mice and suppressed LPS-induced macrophage apoptosis and inflammation in vitro (P<0.05). Network pharmacology analysis showed that FFD could regulate the MAPK14/FOXO signaling pathway during sepsis. As confirmed by in vitro cell experiments, FFD inhibited the MAPK14 signaling pathway or FOXO3A expression to relieve LPS-induced macrophage apoptosis and inflammation (P<0.05). Furthermore, FFD inhibited the MAPK14/FOXO3A signaling pathway to inhibit LPS-induced macrophage apoptosis in the lung tissue of septic mice (P<0.05).
CONCLUSION
FFD could ameliorate the LPS-induced inflammatory response in septic mice by inhibiting the MAPK14/FOXO3A signaling pathway.
Mice
;
Animals
;
Mitogen-Activated Protein Kinase 14/metabolism*
;
Wolfiporia
;
Lipopolysaccharides/pharmacology*
;
Sepsis/complications*
;
Signal Transduction
;
Inflammation/drug therapy*
;
Oxygen Radioisotopes
6.A case of sudden hearing loss combined with familial hyperlipidemia.
Hui ZHONG ; Xiaonan WU ; Jing GUAN ; Dayong WANG ; Qiuju WANG
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2024;38(1):70-72
Hyperlipidemia is characterized by elevated levels of blood lipids. The clinical manifestations are mainly atherosclerosis caused by the deposition of lipids in the vascular endothelium. The link between abnormal lipid metabolism and sudden hearing loss remains unclear. This article presents a case study of sudden hearing loss accompanied by familial hyperlipidemia. Pure tone audiometry indicated intermediate frequency hearing loss in one ear. Laboratory tests showed abnormal lipid metabolism, and genetic examination identified a heterozygous mutation in theAPOA5 gene. Diagnosis: Sudden hearing loss; hypercholesterolemia. The patient responded well to pharmacological treatment. This paper aims to analyze and discuss thepotential connection between abnormal lipid metabolism and sudden hearing loss.
Humans
;
Audiometry, Pure-Tone
;
Deafness/complications*
;
Hearing Loss, Sensorineural/diagnosis*
;
Hearing Loss, Sudden/diagnosis*
;
Hyperlipidemias/complications*
;
Lipids
7.Characteristics and therapeutic strategies of Pott's puffy tumor.
Huiyi DENG ; Zhipeng CHEN ; Xifu WU ; Qintai YANG
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2024;38(1):83-90
Objective:To explore the characteristics and therapeutic strategies of Pott's puffy tumor(PPT). Methods:The clinical data of two patients with PPT were retrospectively analyzed and combined with the literature, focusing on the comprehensive analysis of perioperative diagnosis and treatment strategies. Both patients underwent muti-disciplinary treatment, including timely administration of sufficient antibiotics capable of penetrating the blood-brain barrier. Early removal of PPT lesions was performed using a combined internal and external approach under nasal endoscopic guidance. Results:After standardized perioperative management, the symptoms of the two patients were completely relieved, with no recurrence after one=year follow=up. Postoperative complications such as frontal pain, numbness, local depression, or scar hyperplasiawere not present. Conclusion:PPT, being relatively rare and severe, requires careful attention. Key strategies for standardized perioperative management include multi-disciplinary consultation, timely and adequate antibiotic administration, and surgical intervention using a combined intranasal and extranasal endoscopic approach for lesion removal.
Humans
;
Pott Puffy Tumor/complications*
;
Retrospective Studies
;
Tomography, X-Ray Computed
;
Endoscopy/adverse effects*
;
Postoperative Complications
;
Anti-Bacterial Agents/therapeutic use*
;
Frontal Sinusitis/complications*
8.Chorea Hyperglycemia Basal Ganglia Syndrome: A case report of a rare diabetes complication
Cristina A. Dorado ; Neshreen J. Kingking ; Remirr Theodore P. Nolasco ; Meliza Dadua-Ecal ; Jay S. Fonte
Philippine Journal of Internal Medicine 2024;62(1):326-330
Introduction:
We present a patient with long-standing uncontrolled type 2 diabetes mellitus (T2 DM) who developed
sudden onset of choreiform movement, which rapidly resolved after insulin therapy and haloperidol.
Case Description:
A 53-year-old Filipino male, with T2DM and hypertension for more than 10 years, presented with sudden
onset of hyperkinetic, involuntary, non-patterned, continuous movements of the left upper and lower extremities.
Investigations revealed severe hyperglycemia without acidemia and ketonuria. Cranial computed tomography scan
showed hyperdensity on the right caudate and lentiform nuclei. On cranial magnetic resonance imaging, there was T1-
weighted hyperintense and T2 - weighted hypointense signal involving the right putamen, globus pallidus and caudate.
Cranial magnetic resonance angiography showed stenosis on the cavernous segment of the right internal carotid artery
(ICA), left ICA and middle cerebral artery (MCA) junction, the A1 segment of the left anterior communicating artery and
proximal P2 segments of the bilateral posterior cerebral arteries. The patient was managed with a basal-bolus insulin
regimen to control the blood glucose and haloperidol to manage the extrapyramidal symptoms. Consequently, there was
complete resolution of the involuntary movements.
Conclusion
This case illustrates the importance of a systematic approach to movement disorders and early recognition of
this rare diabetes complication known as chorea hyperglycemia basal ganglia syndrome or diabetic striatopathy.
Movement Disorders
;
Diabetes Complications


Result Analysis
Print
Save
E-mail